Resources
About Us
Microbiology Testing Market by Product (PCR, Mass Spectrometer, HPLC, Stainer, Incubator, Microscopes, Kits, Reagents), Microorganism (Bacteria, Fungi, Virus), Application (Pharmaceutical, F&B, Environment, Cosmetic), End User - Global Forecast to 2030
Report ID: MRHC - 104778 Pages: 210 Jun-2024 Formats*: PDF Category: Healthcare Delivery: 24 to 72 Hours Download Free Sample ReportMicrobiology tests are conducted in various industries such as pharmaceutical, diagnostic, food & beverage, cosmetic, and other industries to detect and restrict harmful microorganisms. The report covers microbiology testing products such as laboratory instruments and analyzers; kits and reagents; and other products, including petri dishes, pipettes, swabs, sterile pack bottles, and plates, to detect various microorganisms such as bacteria, fungi, viruses, and protozoa. These products are majorly used by hospitals and diagnostic labs, analytical and quality laboratories, and academic & research institutes.
The growth of this market is driven by the increasing burden of infectious diseases and outbreaks of epidemics, stringent regulations for microbial contamination in pharmaceutical and food & beverage manufacturing, technological advancements in microbiology testing, and the increasing private-public funding for research on infectious diseases.
The key players operating in the microbiology testing market experienced an initial shrinkage due to operational restrictions imposed on various industries globally. However, after the initial shrinkage, the COVID-19 pandemic positively impacted the global microbiology testing market and created growth opportunities for the key players operating in this market. With increasing health safety concerns amid the COVID-19 pandemic, microbiology testing emerged as a crucial tool to fight against the outbreak.
There is an increased demand for microbiology testing in various industries, including pharmaceutical, diagnostic, food & beverage, cosmetic, and other industries, as the COVID-19 pandemic has forced industries to adopt stringent Total Quality Assurance (TQA) policies. Many countries have loosened up the pandemic restrictions due to a low number of new COVID-19 infections and a rising number of people vaccinated against the disease. Various industries have started to work normally, which is creating demand for microbiology testing products and services.
Click here to: Get a Free Sample Copy of this report
The increasing funding for research on infectious diseases has a significant impact on the growth of the global microbiology testing market. These fundings enable the development of new and advanced microbiology testing technologies and methods, which further leads to the production of more accurate and rapid diagnostic products. For example, in June 2022, the [SK1] U.S. Centers for Disease Control and Prevention (CDC) announced a funding of USD 122.47 million to three Indian medical research institutions, namely, the Indian Council of Medical Research (ICMR), National Institute of Virology (NIV), and National Institute of Epidemiology (NIE)), to prevent avoidable epidemics and support rapid and effective epidemiology and outbreak response and for the early detection of disease threats. This kind of funding allows the development of new and improved methods for detecting infectious diseases and the introduction of advanced molecular diagnostic techniques, such as polymerase chain reaction (PCR). Thus, the increase in funding for research on infectious diseases is driving innovation and improvement in the field of microbiology testing, which is further driving the growth of this market.
Based on product, in 2024, the laboratory instruments and analysers segment is expected to account for the largest share of the microbiology testing market. The large market share of this segment is primarily attributed to rising private-public funding for research on infectious diseases and technological advancements in microbiology testing.
Based on microorganism type, in 2024, the bacteria segment is expected to account for the largest share of the microbiology testing market. The large market share of this segment is primarily attributed to the number of foodborne diseases caused by bacteria and stringent regulations for bacterial contamination in food & beverage manufacturing. Bacterial contamination is the most common type of contamination in many industries. Bacterial contamination is the most common type of contamination in many industries. For example, bacteria such as Bacillus cereus, Campylobacter, Clostridium perfringens, and E. coli are considered harmful when it comes to food safety.
It is also the most common cause of food poisoning. Thus, food manufacturing companies need to strictly comply with GMP guidelines and take additional efforts to ensure that the food is processed in hygienic conditions and free from microbial contaminations. The large market share of this segment is primarily attributed to the large number of foodborne diseases caused by bacteria and stringent regulations for bacterial contamination in food & beverage manufacturing.
Based on application, in 2024, the diagnostic testing segment is expected to account for the largest share of the microbiology testing market. The large market share of this segment is primarily attributed to the rising burden of infectious diseases and outbreaks of epidemics, technological advancements in microbiology testing, rising awareness about early diagnosis and food safety, the need to comply with the regulatory guidelines in respective industries, and improving healthcare expenditure.
Based on end user, in 2024, the hospitals and diagnostic labs segment is expected to account for the largest share of the microbiology testing market. The large market share of this segment is primarily attributed to the large prevalence of infectious diseases such as COVID-19, malaria, dengue, gastrointestinal infections, tuberculosis, and HIV; rising adoption of laboratory instruments in hospitals and diagnostic labs; and technological advancements in terms of automation in microbiology testing.
In 2024, North America is expected to account for the largest share of the global microbiology testing market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The large share of this market is primarily attributed to the large prevalence of infectious diseases, stringent GMP regulation for the manufacturing industry, high penetration of advanced microbiology testing products, and well-established distribution channel for microbiology testing products.
The report includes a competitive landscape based on an extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 3 years. The key players profiled in the global microbiology testing market report include bioMérieux SA (France), Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Bruker Corporation (U.S.), Hologic, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Intertek Group plc (U.K.), Eurofins Scientific S.E. (Luxembourg), and Agilent Technologies, Inc. (U.S.).
Key questions answered in the report:
The global microbiology testing market covers the market size & forecasts of the various microbiology testing products offered by key market players to various industries such as pharmaceutical, diagnostics, food and beverage, and cosmetics, among others. Microbiology testing products are used to detect and restrict harmful microorganisms. The microbiology testing market studied in this report involves the value analysis of various segments and sub-segments of microbiology testing product providers at the regional and country levels.
The global microbiology testing market is projected to reach $21.4 billion by 2030, at a CAGR of 5.9% during the forecast period.
Based on product, the global microbiology testing market is segmented into laboratory instruments and analyzers; kits, stains, culture, media, and reagents; and other products. In 2024, the laboratory instruments and analyzers segment is expected to account for the largest share of the microbiology testing market. The laboratory instruments and analyzers segment is further sub-segmented into microbial identification systems, PCR systems, mass spectrometers, high-performance liquid chromatography (HPLC) systems, laminar air flow systems, microbial air samplers, stainers, culture media systems, cell/colony counters, media preparators, incubators, autoclave, microscopes, and other instruments and analyzers.
Based on microorganism type, in 2024, the bacteria segment is expected to account for the largest share of the microbiology testing market. The large market share of this segment is primarily attributed to the large number of foodborne diseases caused by bacteria and stringent regulations for bacterial contamination in food & beverage manufacturing.
The rising burden of infectious diseases and outbreaks of epidemics, stringent regulations for microbial contamination in pharmaceutical and food & beverage manufacturing, technological advancements in microbiology testing, and the increasing private-public funding for research on infectious diseases are the key factors supporting the growth of this market.
In addition, improving healthcare infrastructure in emerging markets is expected to offer significant growth opportunities for players operating in the microbiology testing market.
Key companies operating in the global microbiology testing market are bioMérieux SA (France), Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Bruker Corporation (U.S.), Hologic, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Intertek Group plc (U.K.), Eurofins Scientific S.E. (Luxembourg), and Agilent Technologies, Inc. (U.S.).
Emerging economies such as India and China are projected to offer significant growth opportunities for companies in this market. The rise in the number of people suffering from infectious diseases, the growing number of diagnostic laboratories, and the improving healthcare infrastructure are the factors expected to offer significant growth opportunities in the Asia-Pacific region.
Published Date: Jul-2024
Published Date: Apr-2023
Published Date: Nov-2019
Please enter your corporate email id here to view sample report.
Subscribe to get the latest industry updates